Device and Method for Coiling a Flexible Material
    3.
    发明申请
    Device and Method for Coiling a Flexible Material 审中-公开
    用于卷绕柔性材料的装置和方法

    公开(公告)号:US20090084882A1

    公开(公告)日:2009-04-02

    申请号:US11862670

    申请日:2007-09-27

    IPC分类号: B21C47/02 B21C47/32 B65D63/12

    摘要: A device and method for coiling a long, slender, flexible material (e.g., an electrical cable). One embodiment of the device includes (1) a cylinder defining a substantially cylindrical exterior surface and (2) a reel, around which the flexible material can be coiled. The substantially cylindrical exterior surface defines a groove for receiving at least part of an open tie (e.g., cable tie), and the reel defines an axial through-opening for removably receiving the cylinder therethrough.

    摘要翻译: 用于卷绕长而细长的柔性材料(例如,电缆)的装置和方法。 该装置的一个实施例包括(1)限定基本上圆柱形外表面的圆柱体和(2)卷轴,柔性材料围绕该卷轴被卷绕。 基本上圆柱形的外表面限定用于容纳至少一部分开式连接带(例如电缆扎带)的凹槽,并且所述卷轴限定一个轴向通孔,用于通过其可移除地容纳所述圆筒。

    Substituted Imidazoline Compounds
    4.
    发明申请

    公开(公告)号:US20130338372A1

    公开(公告)日:2013-12-19

    申请号:US13533606

    申请日:2012-06-26

    IPC分类号: C07D233/28

    CPC分类号: C07D233/28

    摘要: The invention relates to compositions comprising substituted imidazoline compounds including prodrugs, and salts thereof. In some embodiments, the invention relates to the use of these compositions as therapeutic agents, preferably for the treatment of arthritis or cancer. In further embodiments, The invention relates to the pharmaceutical compositions with effective amounts of substituted imidazoline compounds disclosed herein that function as agonist or antagonists of the genetic expression or interactions with transcription factor NF-κB.

    Substituted imidazoline compounds
    5.
    发明授权
    Substituted imidazoline compounds 有权
    取代的咪唑啉化合物

    公开(公告)号:US08252942B2

    公开(公告)日:2012-08-28

    申请号:US12247524

    申请日:2008-10-08

    IPC分类号: C07D233/22

    CPC分类号: C07D233/28

    摘要: The invention relates to compositions comprising substituted imidazoline compounds including prodrugs, and salts thereof. In some embodiments, the invention relates to the use of these compositions as therapeutic agents, preferably for the treatment of arthritis or cancer. In further embodiments, The invention relates to the pharmaceutical compositions with effective amounts of substituted imidazoline compounds disclosed herein that function as agonist or antagonists of the genetic expression or interactions with transcription factor NF-κB.

    摘要翻译: 本发明涉及包含取代的咪唑啉化合物(包括前药)及其盐的组合物。 在一些实施方案中,本发明涉及这些组合物作为治疗剂的用途,优选用于治疗关节炎或癌症。 在进一步的实施方案中,本发明涉及具有有效量的本文公开的取代的咪唑啉化合物的药物组合物,其作为与转录因子NF-κB的遗传表达或相互作用的激动剂或拮抗剂。

    Substituted Imidazoline Compounds
    6.
    发明申请
    Substituted Imidazoline Compounds 有权
    取代的咪唑啉化合物

    公开(公告)号:US20090156830A1

    公开(公告)日:2009-06-18

    申请号:US12247524

    申请日:2008-10-08

    CPC分类号: C07D233/28

    摘要: The invention relates to compositions comprising substituted imidazoline compounds including prodrugs, and salts thereof. In some embodiments, the invention relates to the use of these compositions as therapeutic agents, preferably for the treatment of arthritis or cancer. In further embodiments, The invention relates to the pharmaceutical compositions with effective amounts of substituted imidazoline compounds disclosed herein that function as agonist or antagonists of the genetic expression or interactions with transcription factor NF-κB.

    摘要翻译: 本发明涉及包含取代的咪唑啉化合物(包括前药)及其盐的组合物。 在一些实施方案中,本发明涉及这些组合物作为治疗剂的用途,优选用于治疗关节炎或癌症。 在进一步的实施方案中,本发明涉及具有有效量的本文公开的取代咪唑啉化合物的药物组合物,其作为基因表达的激动剂或拮抗剂或与转录因子NF-κB的相互作用。